What are the indications for cervical cerclage in a pregnant woman at risk for mid‑trimester loss or preterm birth due to cervical insufficiency?

Cervical Cerclage Indications

Cervical cerclage is indicated in three specific clinical scenarios: history-indicated cerclage for women with ≥3 prior second-trimester losses or extreme preterm births without other causes; ultrasound-indicated cerclage when cervical length shortens to ≤25 mm (especially <10 mm) before 24 weeks in women with prior spontaneous preterm birth; and examination-indicated cerclage when painless cervical dilation is detected on physical exam before 24 weeks. 1, 2

History-Indicated Cerclage

Place cerclage at 12–14 weeks in women with classic cervical insufficiency features:

• Three or more prior second-trimester pregnancy losses or extreme premature deliveries without other identifiable causes 1, 2
• Prior second-trimester loss with painless cervical dilation in the absence of labor, rupture of membranes, or placental abruption 2
• Unexplained second-trimester losses with classic historical features 2

Critical caveat: After prior previable preterm prelabor rupture of membranes (PPROM), reserve history-indicated cerclage only for women with classic cervical insufficiency features, as one study showed cerclage after prior previable PPROM was associated with increased odds of preterm birth 2

Ultrasound-Indicated Cerclage

Begin serial transvaginal ultrasound assessment of cervical length at 14–16 weeks in high-risk women (those with prior spontaneous preterm birth or second-trimester loss): 1

• If cervical length ≤25 mm before 24 weeks: Offer ultrasound-indicated cerclage placement 1
• If cervical length <10 mm: Cerclage shows particular benefit, with decreased preterm birth at <35 weeks (39.5% vs 58.0%) 1, 2
• If cervical length 10–25 mm without prior preterm birth: Do NOT place cerclage, as meta-analysis shows no benefit in this population 1, 2

For women with 1–2 prior second-trimester losses and cervical length ≤20 mm: Prescribe vaginal progesterone 200 mg daily as first-line therapy (GRADE 1A recommendation) 1

Consider ultrasound-indicated cerclage only if cervix shortens to <10 mm despite progesterone therapy, based on shared decision-making 1

Examination-Indicated Cerclage

When cervical dilation is detected on physical examination before 24 weeks, particularly when cervical length measures <11–15 mm on ultrasound:

• 30–70% of patients with cervical length <11–15 mm will have cervical dilation ≥1 cm on physical exam 1
• Examination-indicated cerclage should be offered in this scenario 1
• Transvaginal ultrasound is the reference standard for cervical assessment, superior to clinical examination alone 1

Absolute Contraindications to Cerclage

Do NOT place cerclage in the following situations:

• Women without prior preterm birth history who have cervical length 10–25 mm 1, 2, 3
• Arbitrary gestational ages without objective cervical assessment 1
• Multiple gestation pregnancies (twins or higher-order multiples) 3
• Active labor, rupture of membranes, or placental abruption 2, 4
• Intrauterine infection 4

Post-Cerclage Management

Add vaginal progesterone 200 mg daily on the day of cerclage placement and continue until 36–37 weeks' gestation:

• Reduces spontaneous preterm birth at <34 weeks (2.2% vs 18.4%; adjusted OR 0.10) and <37 weeks (9.1% vs 29.7%; adjusted OR 0.24) 1, 2
• This benefit applies to all cerclage types (history-, ultrasound-, or examination-indicated) 1
• If already on vaginal progesterone when cerclage is placed, continue without interruption 1

Activity recommendations after cerclage:

• Permit routine daily activities and light upper-body resistance exercise 1
• Avoid moderate-to-vigorous physical activity 1
• Do NOT prescribe bed rest—it offers no benefit and may be harmful 1

Serial ultrasound monitoring after cerclage is NOT routinely recommended due to insufficient evidence of clinical benefit, though shorter cervical length below cerclage and funneling associate with higher preterm birth rates 1, 2

Instruct patients to report immediately:

• Signs of preterm labor (contractions, pelvic pressure, vaginal bleeding, fluid leakage) 1
• Infection indicators (fever, uterine tenderness, purulent discharge) 1

Management of PPROM with Cerclage in Place

Either removal or leaving cerclage in situ is reasonable after shared decision-making discussion of risks and benefits 1, 2

Common Pitfalls to Avoid

• Do not place cerclage based solely on clinical cervical dilation assessment—transvaginal ultrasound provides superior risk stratification 1
• Do not use 17-alpha hydroxyprogesterone caproate (17-OHPC) for short cervix treatment (GRADE 1B recommendation against) 1
• Do not place cervical pessary due to conflicting trial data and recent safety signals including increased perinatal mortality (GRADE 1B recommendation against) 1
• After conization procedures, use serial cervical length measurements to assess for incompetence rather than automatic cerclage placement 1
• Approximately 69% of high-risk women maintain cervical length >25 mm and do not require cerclage—avoid overtreatment 1